Inhibrx Biosciences, Inc. 4

Kimberly Manhard, via her revocable trust, sold 1,000 shares of Inhibrx Biosciences, Inc. common stock for about $115,000 across two trades.

On September 8 and 9, 2026, Kimberly Manhard, through the Kimberly Joan Manhard Revocable Trust, sold a total of 1,000 shares of Inhibrx Biosciences, Inc. common stock in two 500‑share transactions at average prices of approximately $115.14 and $115.795 per share, respectively, for total proceeds of roughly $115,000. Following these sales, the trust’s direct holdings decreased from 10,000 to 9,000 shares, which Manhard may be deemed to indirectly beneficially own in her capacity as trustee.

Filing Facts

CIK

2007919

Ticker

INBX

Form

4

Source Type

fda

Accession

0001202094-26-000004

Alert Tier

5